AlzChem Group AG / Analyst ratings
Price targets
Analyst ratings
3 analysts rated this company in the past 90 days. The average target price is €147.67, this is a change of -0.9% compared to the current price.
-
Berenberg maintains Alzchem's 'Buy' rating - target 185 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained its rating for Alzchem with a price target of €185. The specialty chemicals company remains optimistic in the medium term, particularly thanks to its diverse end markets in integrated production, wrote Gerhard Orgonas after the third day of the Berenberg conference on Wednesday./ag/mf
Publication of the original study: September 24, 2025 / 3:51 p.m. / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Alzchem's 'Buy' rating - target 185 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained its rating for Alzchem with a price target of €185. The specialty chemicals company remains optimistic in the medium term, particularly thanks to its diverse end markets in integrated production, wrote Gerhard Orgonas after the third day of the Berenberg conference on Wednesday./ag/mf
Publication of the original study: September 24, 2025 / 3:51 p.m. / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research raises target for Alzchem to 161 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research raised its price target for Alzchem from €119 to €161 following second-quarter figures and maintained its rating at "Buy." Thanks to its specialty chemicals business, the company has met expectations, wrote Oliver Schwarz in a study published Friday./rob/mis
Publication of the original study: August 15, 2025 / 8:15 a.m. / Time zone not specified in study
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg raises target for Alzchem to 185 euros - 'Buy'
HAMBURG (dpa-AFX Analyser) - The private bank Berenberg raised its price target for Alzchem from 145 to 185 euros following the quarterly figures published the day before and left the rating at "Buy". In response to the specialty chemicals company's renewed strong results, Gerhard Orgonas wrote in a study released Thursday that he has significantly increased his earnings forecasts for the years 2025 to 2027./rob/edh/ck
Publication of the original study: July 30, 2025 / 4:10 p.m. / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Baader Bank maintains Alzchem at 'Add' - target 97 euros
MUNICH (dpa-AFX Analyst) - Baader Bank has maintained its rating for Alzchem at "Add" after the company's results, with a price target of €97. This year's forecast has been confirmed, wrote Konstantin Wiechert in a study released Wednesday. The results are in line with expectations. This will likely not be enough to generate further upward momentum for the shares. The company's forecast strong growth has been priced in./tih/ajx
Publication of the original study: July 30, 2025 / 8:11 a.m. / CEST
First distribution of the original study: Date not specified in study / Time not specified in study / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research maintains Alzchem's 'Buy' rating - target 119 euros
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has maintained its "Buy" rating for Alzchem after the company's results, with a price target of €119. At first glance, the results appear to be in line with expectations, wrote Oliver Schwarz in a study published Wednesday. He also mentioned the confirmed outlook./tih/nas
Publication of the original study: July 30, 2025 / 8:15 a.m. / CEST
First distribution of the original study: Date not specified in study / Time not specified in study / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg raises target for Alzchem to 145 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg raised its price target for Alzchem from €120 to €145 following first-quarter results and maintained its "Buy" rating. Analyst Gerhard Orgonas raised his long-term earnings expectations in a study published Thursday. The specialty chemicals company's product mix continues to improve. The company is also a potential beneficiary of the US tariffs./tih/ajx
Publication of the original study: May 7, 2025 / 4:11 PM / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research maintains Alzchem's 'Buy' rating - target 119 euros
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has maintained its rating for Alzchem at "Buy" after the company's earnings release, with a price target of €119. The chemical company's first quarter fell slightly short of expectations, wrote analyst Oliver Schwarz in a quick assessment published Wednesday. Meanwhile, the outlook for the full year has been confirmed./mf/gl
Publication of the original study: April 30, 2025 / 8:15 a.m. / CEST. First distribution of the original study: Date not specified in study / Time not specified in study / CEST.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Baader Bank maintains Alzchem at 'Add' - target 97 euros
MUNICH (dpa-AFX Analyst) - Baader Bank has maintained its rating for Alzchem at "Add" with a price target of €97. The specialty chemicals segment performed as expected, while Basics & Intermediates performed weaker, analyst Konstantin Wiechert wrote on Wednesday after the quarterly results. Alzchem remains on track to meet its annual targets./ajx/gl
Publication of the original study: April 30, 2025 / 7:32 a.m. / CEST First distribution of the original study: Date not specified in study / Time not specified in study / CEST
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research raises target for Alzchem to 119 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has raised its price target for Alzchem from €80 to €119 and maintained its rating at "Buy." Another record year is in sight for 2025, wrote analyst Oliver Schwarz in his review of the figures released on Tuesday./ag/edh
Publication of the original study: March 18, 2025 / 8:15 a.m. / CET
First distribution of the original study: Date not specified in study / Time not specified in study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg raises target for Alzchem to 120 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has raised its price target for Alzchem from €73 to €120 and maintained its "Buy" rating. Analyst Gerhard Orgonas raised his earnings per share estimates for the chemical company through 2027 in a study released Tuesday. He cited the strong figures for 2024 and a meeting with CEO Andreas Niedermaier at a Berenberg Bank conference. He has now taken into account, among other things, Alzchem's medium-term target of approximately one billion euros in sales with an operating profit margin of 20 percent./ck/tih
Publication of the original study: March 10, 2025 / 5:00 p.m. / GMT
First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Baader Bank raises target for Alzchem to 97 euros - 'Add'
MUNICH (dpa-AFX Analyst) - Baader Bank has raised its price target for Alzchem from €72 to €97 and maintained its rating at "Add." In view of the significantly rising price-earnings-growth (PEG) ratio, analyst Konstantin Wiechert is initially somewhat more cautious on the specialty chemicals company's shares, according to his commentary published on Friday. However, the medium-term outlook is good. With its new price target, Alzchem would be on par with its competitors based on the 2026 estimates./ag/mf
Publication of the original study: March 7, 2025 / 8:58 a.m. / CET
First distribution of the original study: Date not specified in study / Time not specified in study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Warburg Research maintains Alzchem's 'Buy' rating - target €80
HAMBURG (dpa-AFX Analyst) - The analyst firm Warburg Research has maintained its rating for Alzchem at "Buy" with a price target of €80 following the company's earnings release. The chemical company's 2024 figures were better than expected, wrote analyst Oliver Schwarz in a quick assessment released Friday. The development of free cash flow was favorable. The positive trend is expected to continue in 2025./mf
Publication of the original study: February 28, 2025 / 8:15 a.m. / CET. First distribution of the original study: Date not specified in study / Time not specified in study / CET.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG), Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg maintains Alzchem's 'Buy' rating - target 73 euros
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg has maintained a "Buy" rating on Alzchem with a price target of €73. In an outlook published Tuesday, analyst Gerhard Orgonas lists Scout24, Hypoport, Ionos, and Alzchem among the likely winners of the expected new federal government led by the CDU/CSU. Their focus on increased equipment and material reserves for the country's armed forces reflected recent EU subsidies for the specialty chemicals group Alzchem./gl/mis
Publication of the original study: February 10, 2025 / 2:12 PM / GMT. First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Berenberg raises target for Alzchem to 73 euros - 'Buy'
HAMBURG (dpa-AFX Analyst) - Private bank Berenberg raised its price target for Alzchem from €67 to €73 following third-quarter results and maintained its "Buy" rating. Thanks to a favorable product portfolio, operating profit (EBITDA) exceeded the consensus estimate by nine percent, analyst Gerhard Orgonas wrote in a study published Wednesday. Looking ahead to the full year, the specialty chemicals group could once again exceed its EBITDA target./bek/gl
Publication of the original study: December 10, 2024 / 5:23 PM / GMT. First distribution of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study.
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.
-
Baader Bank maintains Alzchem at 'Add' - target 72 euros
MUNICH (dpa-AFX Analyst) - Baader Bank has maintained its rating for Alzchem at "Add" with a price target of €72. Analyst Konstantin Wiechert raised his estimates for the chemical company in his commentary published on Monday, citing the recent slightly better-than-expected quarterly figures. In his opinion, Trump's tariffs are likely to have little impact, as the company should be able to pass much of this on to its customers./ag/tih
Publication of the original study: November 10, 2024 / 8:00 PM / CET
First distribution of the original study: November 11, 2024 / Time not specified in the study / CET
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 (1) of the German Securities Trading Act (WpHG) and Article 20 of Regulation (EU) No. 596/2014 for the aforementioned analyst firm can be found at http://web.dpa-afx.de/offenlegungspflicht/offenlegungs_pflicht.html.